Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Shares Issued: 2020-2024

Historic Shares Issued for Candel Therapeutics (CADL) over the last 4 years, with Dec 2024 value amounting to $1.7 million.

  • Candel Therapeutics' Shares Issued was N/A to $36,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $71.0 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Candel Therapeutics' Shares Issued is $1.7 million, which was up 2,539.06% from $64,000 recorded in FY2022.
  • Candel Therapeutics' Shares Issued's 5-year high stood at $71.3 million during FY2021, with a 5-year trough of $30,000 in FY2020.
  • For the 2-year period, Candel Therapeutics' Shares Issued averaged around $876,500, with its median value being $876,500 (2022).
  • Its Shares Issued has fluctuated over the past 5 years, first surged by 237,683.33% in 2021, then slumped by 99.91% in 2022.
  • Over the past 4 years, Candel Therapeutics' Shares Issued (Yearly) stood at $30,000 in 2020, then spiked by 237,683.33% to $71.3 million in 2021, then slumped by 99.91% to $64,000 in 2022, then reached $1.7 million in 2024.